- Home
- MTCH vs BIO Comparison
MTCH vs BIO Comparison
Compare MTCH & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | BIO |
|---|---|---|
| Founded | 1986 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.2B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTCH | BIO |
|---|---|---|
| Price | $30.50 | $270.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $35.42 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 3.7M | 291.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | ★ 17.82 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $3,487,197,000.00 | N/A |
| Revenue This Year | $2.26 | $2.51 |
| Revenue Next Year | $3.90 | $3.17 |
| P/E Ratio | $13.23 | ★ $9.72 |
| Revenue Growth | ★ 0.22 | N/A |
| 52 Week Low | $26.41 | $211.43 |
| 52 Week High | $39.20 | $343.12 |
Technical Indicators
Market Signals| Indicator | MTCH | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 39.31 |
| Support Level | $29.63 | $266.71 |
| Resistance Level | $33.04 | $290.01 |
| Average True Range (ATR) | 0.93 | 7.90 |
| MACD | -0.01 | 1.40 |
| Stochastic Oscillator | 35.38 | 47.08 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.